# FDA Inspection 1234412 - Amgen Inc. - July 30, 2024

Source: https://www.keypedia.com/records/fda_inspections/amgen-inc/a9fcf4aa-8670-4e0c-9f32-453a0e3acf16
Source feed: FDA_Inspections

> FDA Inspection 1234412 for Amgen Inc. on July 30, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1234412
- Company Name: Amgen Inc.
- Inspection Date: 2024-07-30
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1293010 - 2025-11-06](https://www.keypedia.com/records/fda_inspections/amgen-inc/36d99e51-c9e8-4159-ba2f-2c7bf540403e)
- [FDA Inspection 1293010 - 2025-11-06](https://www.keypedia.com/records/fda_inspections/amgen-inc/fa1bdcd1-cd95-435e-a357-cacef4563079)

Company: https://www.keypedia.com/companies/amgen-inc/ebaa268e-d67a-4623-8e1b-ed5f19dbbf2b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c